Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/35466
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLachowicz, Julia A-
dc.contributor.authorSmallwood, Natasha E-
dc.contributor.authorPrasad, Jyotika D-
dc.contributor.authorPatel, Purab-
dc.contributor.authorVoutier, Catherine-
dc.contributor.authorKhor, Yet H-
dc.contributor.authorSteinfort, Daniel P-
dc.date2024-
dc.date.accessioned2024-09-12T00:46:49Z-
dc.date.available2024-09-12T00:46:49Z-
dc.date.issued2024-07-
dc.identifier.citationEuropean Respiratory Review : an Official Journal of the European Respiratory Society 2024-07; 33(173)en_US
dc.identifier.issn1600-0617-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/35466-
dc.description.abstractTransbronchial lung cryobiopsy (TBLC) is an alternative to surgical lung biopsy for histopathological evaluation of unclassifiable interstitial lung disease (ILD) or ILD diagnosed with low confidence. This meta-analysis synthesised current literature regarding cryobiopsy diagnostic performance and safety, focusing on procedural and sampling techniques. Medline and Embase were searched on 11 April 2022. Studies included adults with unclassifiable ILD, reporting diagnostic yield, complications and methodological techniques of TBLC. Meta-analyses were performed for diagnostic yield, pneumothorax and bleeding. Subgroup analyses and meta-regression assessed methodological variables. PROSPERO registration: CRD42022312386. 70 studies were included with 6183 participants. Diagnostic yield of TBLC was 81% (95% CI 79-83%, I2=97%), with better yield being observed with general anaesthesia (p=0.007), ILD multidisciplinary meeting prior to cryobiopsy (p=0.02), 2.4 mm cryoprobe (p=0.04), higher mean forced vital capacity (p=0.046) and higher mean diffusing capacity for carbon monoxide (p=0.023). Pneumothorax rate was 5% (95% CI 4-5%, I2=91%), with higher rates associated with a 2.4 mm cryoprobe (p<0.00001), routine post-procedure imaging (p<0.00001), multiple lobe sampling (p<0.0001), reduced mean diffusing capacity for carbon monoxide (p=0.028) and general anaesthesia (p=0.05). Moderate-to-severe bleeding rate was 12% (11-14%, I2=95%) and higher rates were associated with a 2.4 mm cryoprobe (p=0.001) and bleeding score selection (p=0.04). Patient characteristics and modifiable factors, including procedural methods and anaesthetic techniques, impacted diagnostic yield and safety outcomes of TBLC in people with unclassifiable ILD and contributed to heterogeneity of clinical outcomes. These variables should be considered for individualised clinical decision making and guideline development and warrant routine reporting in future research.en_US
dc.language.isoeng-
dc.titleA systematic review of procedural and sampling techniques for cryobiopsy in interstitial lung disease.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleEuropean Respiratory Review : an Official Journal of the European Respiratory Societyen_US
dc.identifier.affiliationDepartment of Respiratory Medicine, Royal Melbourne Hospital, Melbourne, Australia.;Faculty of Medicine, University of Melbourne, Melbourne, Australia.en_US
dc.identifier.affiliationDepartment of Respiratory Medicine, The Alfred, Melbourne, Australia.;Faculty of Medicine, Monash University, Melbourne, Australia.en_US
dc.identifier.affiliationDepartment of Respiratory Medicine, Royal Melbourne Hospital, Melbourne, Australia.;Faculty of Medicine, Monash University, Melbourne, Australia.;Department of Respiratory Medicine and Lung Transplant Unit, The Alfred, Melbourne, Australia.;University of Melbourne, Melbourne, Australia.en_US
dc.identifier.affiliationNova Southeastern University, Fort Lauderdale, FL, USA.en_US
dc.identifier.affiliationHealth Sciences Library, Royal Melbourne Hospital, Melbourne, Australia.en_US
dc.identifier.affiliationRespiratory and Sleep Medicineen_US
dc.identifier.affiliationDepartment of Respiratory Medicine, Royal Melbourne Hospital, Melbourne, Australia.;Faculty of Medicine, University of Melbourne, Melbourne, Australia.en_US
dc.identifier.affiliationInstitute for Breathing and Sleepen_US
dc.identifier.doi10.1183/16000617.0035-2024en_US
dc.type.contentTexten_US
dc.identifier.orcid0000-0002-4854-108Xen_US
dc.identifier.orcid0000-0002-5434-9342en_US
dc.identifier.orcid0000-0002-8998-2949en_US
dc.identifier.pubmedid39142710-
dc.description.volume33-
dc.description.issue173-
dc.subject.meshtermssecondaryLung Diseases, Interstitial/pathology-
dc.subject.meshtermssecondaryLung Diseases, Interstitial/diagnosis-
dc.subject.meshtermssecondaryBiopsy/adverse effects-
dc.subject.meshtermssecondaryBiopsy/methods-
dc.subject.meshtermssecondaryCryosurgery/adverse effects-
dc.subject.meshtermssecondaryCryosurgery/methods-
dc.subject.meshtermssecondaryLung/pathology-
dc.subject.meshtermssecondaryBronchoscopy/adverse effects-
dc.subject.meshtermssecondaryBronchoscopy/methods-
dc.subject.meshtermssecondaryBronchoscopy/instrumentation-
dc.subject.meshtermssecondaryPneumothorax/etiology-
item.cerifentitytypePublications-
item.languageiso639-1en-
item.grantfulltextnone-
item.openairetypeJournal Article-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.deptRespiratory and Sleep Medicine-
crisitem.author.deptInstitute for Breathing and Sleep-
crisitem.author.deptMedicine (University of Melbourne)-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

16
checked on Nov 2, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.